Clinical Trials Sponsored by EPS SURA

Total 1071 results

Hemab ApS

Recruiting

A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia

Glanzmann Thrombasthenia

United States, Belgium, France, Italy, Netherlands, United Kingdom
SPS srl

Not yet recruiting

SPACE (SPS ADVANCED CAGE): SPS Spacer for Intervertebral Fusion, Longitudinal, Prospective Clinical Study (SPACE)

Treatment of Degenerative Diseases of the Spine

Italy
Cell2Cure ApS

Recruiting

ASC - Autism Study

Inflammatory Bowel Diseases | Autism Spectrum Disorder | Gastrointestinal Dysfunction | Mesenchymal Stromal Cells | Leaky Gut Syndrome

Denmark
Cell2Cure ApS

Recruiting

Effect of Mesenchymal Stem Cells on Healing of Foot Ulcers in Diabetes Patients. (STEMFOOT)

Diabetic Foot Ulcer | Mesenchymal Stromal Cells

Denmark
Hedia ApS

Completed

HEdia eXercise Algorithm - HEXA Study.

Diabetes

Denmark
EPI-PHARE

Completed

Routine Surgical Procedures During COVID-19 Pandemic: a French Nationwide Cohort Study

Cataract | Surgery | Knee Arthroplasty | COVID-19 Pandemic | Hip Arthroplasty | Pacemaker | Coronary Stent

France
RhoVac APS

Active, not recruiting

Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer (BRaVac)

Prostate Cancer Recurrent

Sweden, United States, Finland, United Kingdom, Belgium, Germany, Denmark
Minervax ApS

Completed

Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non-pregnant Women 18-40 Years of Age. (MVX13211)

Infection by Streptococcus Group B

United Kingdom
Aura Biosciences

Active, not recruiting

Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

Ocular Melanoma | Uveal Melanoma | Choroidal Melanoma

United States
Aura Biosciences

Terminated

Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM) (IL)

Choroidal Melanoma | Indeterminate Lesions

United States
AURA Sante

Unknown

Long Term Physical Activity for Hemodialysis Patients

End Stage Renal Disease on Hemodialysis
Vesper Biotechnologies ApS

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001 in Healthy Participants (SORT-IN-1)

Dementia, Frontotemporal

Netherlands
Radiometer Medical ApS

Recruiting

ABL90 Flex Plus Method Comparison Study_Adults

Diagnostic Test

United States
Radiometer Medical ApS

Completed

Clinical Performance Evaluation of AQT90 FLEX BNP and NT-proBNP

Heart Failure

United States
Sure, Inc.
MaineHealth

Not yet recruiting

Evaluation of the Bexa™ Breast Examination (BBE)

Breast Cancer
Kura Oncology, Inc.

Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, or 7+3 in Patients With AML

Acute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse | Myeloid Sarcoma | Acute Myeloid Leukemia Recurrent | Mixed Phenotype Acute Leukemia | Mixed Lineage Acute Leukemia | Refractory AML | NPM1 Mutation | Mixed Lineage Leukemia Gene Mutation | AML With Mutated NPM1 | KMT2Ar

United States
Kura Oncology, Inc.

Recruiting

First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia | Acute Leukemia of Ambiguous Lineage | Advanced Malignant Neoplasm | Mixed Phenotype Acute Leukemia | Mixed Lineage Leukemia | Mixed Lineage Acute Leukemia

United States, Spain, United Kingdom, France, Germany, Canada, Belgium, Italy
Kura Oncology, Inc.

Available

Expanded Access to Ziftomenib

Acute Lymphoblastic Leukemia, With Appropriate Mutations | Acute Myeloid Leukemia, With NPM1 Mutations
Kura Oncology, Inc.

Terminated

Cardiovascular Safety Study of Tipifarnib in Patients With Advanced Solid Malignancies

Advanced Solid Tumor

United States
Kura Oncology, Inc.

Terminated

First-in-Human Study of KO-947 in Non-Hematological Malignancies

Advanced Malignant Neoplasm

United States, Spain
Kura Oncology, Inc.

Completed

Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations

Thyroid Cancer | Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) | HRAS Mutant Tumor | Other Squamous Cell Carcinoma (SCC) With HRAS Mutant Tumor

Spain, United States, Korea, Republic of, France, Belgium, Germany, Greece, Italy, Netherlands, United Kingdom
Kura Oncology, Inc.

Completed

Investigation of Tipifarnib in Treatment of Subjects With PTCL That Have Not Responded to Standard Therapy. (PTCL)

Relapsed or Refractory Peripheral T-Cell Lymphoma

United States, Spain, Korea, Republic of
Kura Oncology, Inc.

Terminated

Tipifarnib in Subjects With Myelodysplastic Syndromes

Myelodysplastic Syndromes

United States
Radiometer Medical ApS

Recruiting

ABL90 FP MC Neonatal Arterial, Venous, Capillary Blood

Congenital Heart Disease

United States
Haemnet
Hemab ApS

Recruiting

The Lived Experience of People With Von Willebrand Disease (VWD360)

Von Willebrand Diseases

United Kingdom
Radiometer Medical ApS

Recruiting

ABL90 FLEX PLUS Clinical Precision Study for ctBil and FHbF Parameters in Neonatal Whole Blood

Blood Tests

Denmark
Haemnet
Hemab ApS

Completed

The Experiences of People Who Live With Glanzmanns Thrombasthenia.

Glanzmann Thrombasthenia

United Kingdom
Radiometer Medical ApS

Completed

ABL90 FLEX PLUS Clinical Precision Study for 15 Parameters in Adult Whole Blood

Diagnostic Test

Denmark
Freya Biosciences ApS

Completed

FB101 Intervention in Women Screened to Have Vaginal Dysbiosis (DYSCOVER-1)

Vaginal Flora Imbalance

Ireland
SynAct Pharma Aps

Completed

A Study of the Safety, Tolerability and Efficacy of Treatment With AP1189 in Early RA Patients With Active Joint Disease (SynAct-CS002)

Rheumatoid Arthritis

Denmark, Norway
Liita Care ApS

Unknown

Nasal Muco-ciliary Clearance Study With and Without Salt Inhalation

Obstructive Airway Diseases

Denmark
Aros Pharma ApS

Completed

Investigation of Efficacy and Safety of PPC-5650 to Experimental Induced Sensation and Pain in the Rectosigmoid

Pain

Sweden
Hyben Vital ApS

Completed

A Double-blind, Randomized, Parallel Group, Fase III Comparative Study With Rose Hip Powder Powder and Placebo Given to Patients With Mild to Moderate Osteoarthritis in the Knee or/and Hip

Quality of Life | Pain | Activities of Daily Living

Denmark
Kura Oncology, Inc.

Recruiting

Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

HNSCC

United States
Kura Oncology, Inc.

Available

Expanded Access to Tipifarnib

HRAS Mutations or Peripheral T Cell Lymphoma (PTCL)
Kura Oncology, Inc.

Completed

Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other MDS/MPN, and Acute Myeloid Leukemia (CMML/AML)

Leukemia, Myelomonocytic, Chronic

United States
Sera Prognostics, Inc.

Completed

Proteomic Assessment of Preterm Birth (PAPR)

Preterm Birth

United States
Cura Biotech LLC

Unknown

A Study Evaluating the Safety and Efficacy of Cura-100 in Subjects With Rheumatoid Arthritis and Osteoarthritis

Osteoarthritis | Rheumatoid Arthritis

United States
Freya Biosciences ApS

Recruiting

FB101 Intervention in Women Screened to Have Vaginal Dysbiosis (Dyscover-3) (Dyscover-3)

Vaginal Flora Imbalance

Ireland
SynAct Pharma Aps

Recruiting

A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria

Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy | Severe Proteinuria Due to Idiopathic Membranous Nephropathy

Denmark
Liita Care ApS

Suspended

Muco-ciliary Cleansing of Lungs in COPD With and Without a Salt Particle Inhaler

COPD | Copd Bronchitis

Denmark
Radiometer Medical ApS

Completed

Clinical Performance Evaluation of AQT90 FLEX TnI and TnT

Myocardial Infarction

United States
Hyben Vital ApS

Completed

A Double-blind, Randomised, Parallel Group,Comparative Study With Rose-hip Liquid and Placebo Given to Healthy Volunteers in the Winter Season Aiming to Evaluate the Occurences of Flu and Catching a Cold

Common Cold | Flu

Denmark
Nycomed
NPS Pharma

Completed

Pharmacokinetics of 10 mg Teduglutide in Subjects With Renal Impairment Compared to Healthy Subjects With Normal Renal Function

Renal Impairment

Germany
LifeScan
Synexus(UK); CPS(UK); Battelle CRO(US); RPS CRO(US); Robertson Centre For Biostatistics...

Completed

Clinical Benefits of a Blood Glucose Monitoring System in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States, United Kingdom, Canada
Kura Oncology, Inc.

Recruiting

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Neoplasms by Histologic Type | Acute Myeloid Leukemia | Leukemia | Leukemia, Myeloid | Leukemia, Myeloid, Acute | AML | Acute Leukemia | Hematologic Malignancy | NPM1 Mutation | AML With Mutated NPM1 | KMT2Ar | MLL Rearrangement

United States
Kura Oncology, Inc.

Withdrawn

Tipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer

NSCLC

United States
Kura Oncology, Inc.

Active, not recruiting

Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy (AIM-HN/SEQ-HN)

HNSCC | HRAS Gene Mutation

United States, Belgium, Spain, United Kingdom, Taiwan, Denmark, Korea, Republic of, Netherlands, Thailand, Germany, Malaysia, Austria, Italy, Greece, Australia, Norway
Sera Prognostics, Inc.

Completed

A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor (TREETOP)

Preterm Birth

United States
Fondazione Italiana Linfomi - ETS

Not yet recruiting

Retrospective-prospective Study to Evaluate Treatment Management and Outcomes of Patients With Waldenström's Macroglobulinemia (WM) Treated in Italy According to the Zanubrutinib (Brukinsa®) Compassionate Use Program (CUP) and in Common Practice Following Commercial Approval.

Waldenström's Macroglobulinemia (WM)

Italy

Clinical Trials Sponsored by EPS SURA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations